THE GENITAL PSORIASIS WELLNESS CONSORTIUM Trademark

Trademark Overview


On Monday, January 22, 2024, a trademark application was filed for THE GENITAL PSORIASIS WELLNESS CONSORTIUM with the United States Patent and Trademark Office. The USPTO has given the THE GENITAL PSORIASIS WELLNESS CONSORTIUM trademark a serial number of 98369450. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, October 27, 2025. This trademark is owned by Arcutis Biotherapeutics, Inc.. The THE GENITAL PSORIASIS WELLNESS CONSORTIUM trademark is filed in the Advertising, Business and Retail Services and Education & Entertainment Services categories with the following description:

Providing educational services to healthcare providers and patients, namely, providing presentations, seminars, webinars, workshops, publications, posters, pamphlets, brochures, videos, commercials, newsletters and information via emails, social media content, tradeshow materials, product theaters, and healthcare professional promotional materials in the field of disease diagnosis and disease management

Promoting public interest and awareness of autoimmune conditions by means of public advocacy
the genital psoriasis wellness consortium

General Information


Serial Number98369450
Word MarkTHE GENITAL PSORIASIS WELLNESS CONSORTIUM
Filing DateMonday, January 22, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateMonday, October 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedThe color(s) yellow and black is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the black stylized wording "The Genital Psoriasis Wellness Consortium" stacked vertically. The wording "Genital Psoriasis Wellness" is in stylized font and appears over three yellow vertically-stacked rectangles. The color white is not a claimed feature of the mark and represents background.
Goods and ServicesProviding educational services to healthcare providers and patients, namely, providing presentations, seminars, webinars, workshops, publications, posters, pamphlets, brochures, videos, commercials, newsletters and information via emails, social media content, tradeshow materials, product theaters, and healthcare professional promotional materials in the field of disease diagnosis and disease management
Goods and ServicesPromoting public interest and awareness of autoimmune conditions by means of public advocacy

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, January 22, 2024
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameArcutis Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestlake Village, CA 91361

Trademark Events


Event DateEvent Description
Monday, January 22, 2024NEW APPLICATION ENTERED
Wednesday, May 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 16, 2024ASSIGNED TO EXAMINER
Tuesday, August 20, 2024NON-FINAL ACTION WRITTEN
Tuesday, August 20, 2024NON-FINAL ACTION E-MAILED
Tuesday, August 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 27, 2025FINAL REFUSAL WRITTEN
Monday, October 27, 2025FINAL REFUSAL E-MAILED
Monday, October 27, 2025NOTIFICATION OF FINAL REFUSAL EMAILED